IMRIS Inc. (IMRS)

Check out top investors' recommendation for IMRS
Last closing price (Aug 29 4:00 EDT):
0.82 (-10.87%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
-21.15% ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
N/A
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
N/A
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
IMRIS Inc. designs, manufactures, and sells image-guided therapy systems that enable surgeons to obtain information and make decisions during the course of procedures. It offers VISIUS Surgical Theatres, which deliver detailed visual information to clinicians during the course of various traditional surgical procedures, including neurological, cardiovascular, cerebrovascular, interventional, and spine. The company’s products in development include SYMBIS Surgical System, a surgeon controlled robot capable of performing microsurgery and other stereotactic procedures under real time image guidance; and the TrueBeam System for Radiosurgery, which would enable the use of MR imaging during radiotherapy treatments for cancer. The company serves hospitals worldwide. IMRIS Inc. is based in Winnipeg, Canada.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Alan Ridgeway Paradigm Capital Inc. Buy   May 05, '14   1.20    May 05, '15  -31.67% 
Jason Mills Canaccord Genuity Buy   Feb 20, '14   2.63    Feb 20, '15  -68.82% 
Jason Mills Canaccord Genuity Buy   Nov 05, '13   1.48  2.20  Nov 05, '14  48.65% 
Alan Ridgeway Paradigm Capital Inc. Buy   Mar 12, '13   3.58  5.50  Mar 12, '14  -51.12% 
Alan Ridgeway Paradigm Capital Inc. Buy   Sep 30, '12   4.53  7.00  Sep 30, '13  -64.24% 
Sean Lavin Lazard Capital Markets Buy   Jan 05, '11   6.08  9.00  Jan 05, '12  -58.06%